MicroRNAs and epigenetics

FEBS Journal

Volumn 278, Issue 10, 2011, Pages 1598-1609

  Sato, Fumiaki ^a   Tsuchiya, Soken ^a   Meltzer, Stephen J ^b   Shimizu, Kazuharu ^a  

^a KYOTO UNIVERSITY   (Japan)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

DNA methylation; epigenetics; histone modification; microRNA

Indexed keywords

BMI1 PROTEIN; DNA; DNA METHYLTRANSFERASE; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; HISTONE; HISTONE DEACETYLASE; LET 7A; MICRORNA; MICRORNA 124; MICRORNA 137; MICRORNA 148; MICRORNA 203; MICRORNA 34A; MICRORNA 9; TRANSCRIPTION FACTOR EZH2; TRANSCRIPTION FACTOR YY1; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ACUTE LYMPHOBLASTIC LEUKEMIA; BIOGENESIS; BREAST CANCER; CARCINOGENESIS; COLON CANCER; DNA METHYLATION; EPIGENETICS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE LOCUS; GENE REPRESSION; GENE SILENCING; GENOME IMPRINTING; HEAD AND NECK CANCER; HISTONE MODIFICATION; HUMAN; MELANOMA; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REVIEW; RNA INTERFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; GENOMIC IMPRINTING; HISTONE DEACETYLASES; HUMANS; MICRORNAS; PROTEINS; REPRESSOR PROTEINS; RIBONUCLEASE III; RNA POLYMERASE II;

EID: 79955581917     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2011.08089.x     Document Type: Review

References (96)

1. Lee RC, Feinbaum RL, &, Ambros V, (1993) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75, 843-854. (Pubitemid 24014542)
2. Lagos-Quintana M, Rauhut R, Lendeckel W, &, Tuschl T, (2001) Identification of novel genes coding for small expressed RNAs. Science 294, 853-858. (Pubitemid 33032103)
3. Lau NC, Lim LP, Weinstein EG, &, Bartel DP, (2001) An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 294, 858-862. (Pubitemid 33032104)
4. Lee RC, &, Ambros V, (2001) An extensive class of small RNAs in Caenorhabditis elegans. Science 294, 862-864. (Pubitemid 33032105)
5. Ambros V, Bartel B, Bartel DP, Burge CB, Carrington JC, Chen X, Dreyfuss G, Eddy SR, Griffiths-Jones S, Marshall M, et al. (2003) A uniform system for microRNA annotation. RNA 9, 277-279. (Pubitemid 36246165)
6. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297.
7. Griffiths-Jones S, (2004) The microRNA Registry. Nucleic Acids Res 32, D109-D111. (Pubitemid 38081615)
8. Kim VN, &, Nam JW, (2006) Genomics of microRNA. Trends Genet 22, 165-173. (Pubitemid 43290020)
9. Zamore PD, &, Haley B, (2005) Ribo-gnome: the big world of small RNAs. Science 309, 1519-1524. (Pubitemid 41266468)
10. Nakahara K, &, Carthew RW, (2004) Expanding roles for miRNAs and siRNAs in cell regulation. Curr Opin Cell Biol 16, 127-133. (Pubitemid 38757288)
11. Ichimura A, Ruike Y, Terasawa K, &, Tsujimoto G, (2011) MicoRNAs and regulation of cell signaling. FEBS J 278, 1610-1618.
12. Ono K, Kuwabara Y, &, Han J, (2011) MicroRNAs and cardiovascular diseases. FEBS J 278, 1619-1633.
13. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, et al. (2005) MicroRNA expression profiles classify human cancers. Nature 435, 834-838. (Pubitemid 40839735)
14. Berdasco M, &, Esteller M, (2010) Aberrant epigenetic landscape in cancer: how cellular identity goes awry. Dev Cell 19, 698-711.
15. Taby R, &, Issa J-PJ, (2010) Cancer epigenetics. CA Cancer J Clin 60, 376-392.
16. Guil S, &, Esteller M, (2009) DNA methylomes, histone codes and miRNAs: tying it all together. Int J Biochem Cell Biol 41, 87-95.
17. Chuang JC, &, Jones PA, (2007) Epigenetics and microRNAs. Pediatr Res 61, 24R-29R. (Pubitemid 46653064)
18. Veeck J, &, Esteller M, (2010) Breast cancer epigenetics: from DNA methylation to microRNAs. J Mammary Gland Biol Neoplasia 15, 5-17.
19. Kim VN, Han J, &, Siomi MC, (2009) Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol 10, 126-139.
20. Yoda M, Kawamata T, Paroo Z, Ye X, Iwasaki S, Liu Q, &, Tomari Y, (2010) ATP-dependent human RISC assembly pathways. Nat Struct Mol Biol 17, 17-23.
21. Orban TI, &, Izaurralde E, (2005) Decay of mRNAs targeted by RISC requires XRN1, the Ski complex, and the exosome. RNA 11, 459-469. (Pubitemid 40397179)
22. Behm-Ansmant I, Rehwinkel J, Doerks T, Stark A, Bork P, &, Izaurralde E, (2006) mRNA degradation by miRNAs and GW182 requires both CCR4:NOT deadenylase and DCP1:DCP2 decapping complexes. Genes Dev 20, 1885-1898. (Pubitemid 44079326)
23. Vasudevan S, Tong Y, &, Steitz JA, (2007) Switching from repression to activation: microRNAs can up-regulate translation. Science 318, 1931-1934.
24. Chatterjee S, &, Grosshans H, (2009) Active turnover modulates mature microRNA activity in Caenorhabditis elegans. Nature 461, 546-549.
25. Wang X, Xuan Z, Zhao X, Li Y, &, Zhang MQ, (2009) High-resolution human core-promoter prediction with CoreBoost-HM. Genome Res 19, 266-275.
26. Zhou X, Ruan J, Wang G, &, Zhang W, (2007) Characterization and identification of microRNA core promoters in four model species. PLoS Comput Biol 3, e37.
27. Corcoran DL, Pandit KV, Gordon B, Bhattacharjee A, Kaminski N, &, Benos PV, (2009) Features of mammalian microRNA promoters emerge from polymerase II chromatin immunoprecipitation data. PLoS ONE 4, e5279.
28. Toyota M, Suzuki H, Sasaki Y, Maruyama R, Imai K, Shinomura Y, &, Tokino T, (2008) Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Res 68, 4123-4132.
29. Saito Y, Liang G, Egger G, Friedman JM, Chuang JC, Coetzee GA, &, Jones PA, (2006) Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 9, 435-443. (Pubitemid 43832188)
30. Sato F, Tsuchiya S, Terasawa K, &, Tsujimoto G, (2009) Intra-platform repeatability and inter-platform comparability of microRNA microarray technology. PLoS ONE 4, e5540.
31. Roman-Gomez J, Agirre X, Jimenez-Velasco A, Arqueros V, Vilas-Zornoza A, Rodriguez-Otero P, Martin-Subero I, Garate L, Cordeu L, San Jose-Eneriz E, et al. (2009) Epigenetic regulation of microRNAs in acute lymphoblastic leukemia. J Clin Oncol 27, 1316-1322.
32. Bandres E, Agirre X, Bitarte N, Ramirez N, Zarate R, Roman-Gomez J, Prosper F, &, Garcia-Foncillas J, (2009) Epigenetic regulation of microRNA expression in colorectal cancer. Int J Cancer 125, 2737-2743.
33. Lujambio A, Calin GA, Villanueva A, Ropero S, Sanchez-Cespedes M, Blanco D, Montuenga LM, Rossi S, Nicoloso MS, Faller WJ, et al. (2008) A microRNA DNA methylation signature for human cancer metastasis. Proc Natl Acad Sci USA 105, 13556-13561.
34. Lehmann U, Hasemeier B, Christgen M, Muller M, Romermann D, Langer F, &, Kreipe H, (2008) Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer. J Pathol 214, 17-24.
35. Hsu PY, Deatherage DE, Rodriguez BA, Liyanarachchi S, Weng YI, Zuo T, Liu J, Cheng AS, &, Huang TH, (2009) Xenoestrogen-induced epigenetic repression of microRNA-9-3 in breast epithelial cells. Cancer Res 69, 5936-5945.
36. Guo LM, Pu Y, Han Z, Liu T, Li YX, Liu M, Li X, &, Tang H, (2009) MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-kappaB1. FEBS J 276, 5537-5546.
37. He L, He X, Lim LP, de Stanchina E, Xuan Z, Liang Y, Xue W, Zender L, Magnus J, Ridzon D, et al. (2007) A microRNA component of the p53 tumour suppressor network. Nature 447, 1130-1134. (Pubitemid 47014436)
38. Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, Lee KH, Feldmann G, Yamakuchi M, Ferlito M, Lowenstein CJ, et al. (2007) Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 26, 745-752. (Pubitemid 46856245)
39. Lodygin D, Tarasov V, Epanchintsev A, Berking C, Knyazeva T, Korner H, Knyazev P, Diebold J, &, Hermeking H, (2008) Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer. Cell Cycle 7, 2591-2600.
40. Kozaki K, Imoto I, Mogi S, Omura K, &, Inazawa J, (2008) Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. Cancer Res 68, 2094-2105. (Pubitemid 351521781)
41. Pigazzi M, Manara E, Baron E, &, Basso G, (2009) miR-34b targets cyclic AMP-responsive element binding protein in acute myeloid leukemia. Cancer Res 69, 2471-2478.
42. Cao X, Pfaff SL, &, Gage FH, (2007) A functional study of miR-124 in the developing neural tube. Genes Dev 21, 531-536. (Pubitemid 46409468)
43. Silber J, Lim DA, Petritsch C, Persson AI, Maunakea AK, Yu M, Vandenberg SR, Ginzinger DG, James CD, Costello JF, et al. (2008) miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med 6, 14.
44. Agirre X, Vilas-Zornoza A, Jimenez-Velasco A, Martin-Subero JI, Cordeu L, Garate L, San Jose-Eneriz E, Abizanda G, Rodriguez-Otero P, Fortes P, et al. (2009) Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia. Cancer Res 69, 4443-4453.
45. Hackanson B, Bennett KL, Brena RM, Jiang J, Claus R, Chen SS, Blagitko-Dorfs N, Maharry K, Whitman SP, Schmittgen TD, et al. (2008) Epigenetic modification of CCAAT/enhancer binding protein alpha expression in acute myeloid leukemia. Cancer Res 68, 3142-3151.
46. Lujambio A, Ropero S, Ballestar E, Fraga MF, Cerrato C, Setien F, Casado S, Suarez-Gauthier A, Sanchez-Cespedes M, Git A, et al. (2007) Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res 67, 1424-1429. (Pubitemid 46383366)
47. Ando T, Yoshida T, Enomoto S, Asada K, Tatematsu M, Ichinose M, Sugiyama T, &, Ushijima T, (2009) DNA methylation of microRNA genes in gastric mucosae of gastric cancer patients: its possible involvement in the formation of epigenetic field defect. Int J Cancer 124, 2367-2374.
48. Furuta M, Kozaki KI, Tanaka S, Arii S, Imoto I, &, Inazawa J, (2010) miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis 31, 766-776.
49. Bemis LT, Chen R, Amato CM, Classen EH, Robinson SE, Coffey DG, Erickson PF, Shellman YG, &, Robinson WA, (2008) MicroRNA-137 targets microphthalmia-associated transcription factor in melanoma cell lines. Cancer Res 68, 1362-1368. (Pubitemid 351346843)
50. Imoto I, Pimkhaokham A, Watanabe T, Saito-Ohara F, Soeda E, &, Inazawa J, (2000) Amplification and overexpression of TGIF2, a novel homeobox gene of the TALE superclass, in ovarian cancer cell lines. Biochem Biophys Res Commun 276, 264-270.
51. Wellner U, Schubert J, Burk UC, Schmalhofer O, Zhu F, Sonntag A, Waldvogel B, Vannier C, Darling D, zur Hausen A, et al. (2009) The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat Cell Biol 11, 1487-1495.
52. Vrba L, Jensen TJ, Garbe JC, Heimark RL, Cress AE, Dickinson S, Stampfer MR, &, Futscher BW, (2010) Role for DNA methylation in the regulation of miR-200c and miR-141 expression in normal and cancer cells. PLoS ONE 5, e8697.
53. Wiklund ED, Bramsen JB, Hulf T, Dyrskjot L, Ramanathan R, Hansen TB, Villadsen SB, Gao S, Ostenfeld MS, Borre M, et al. (2011) Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancer. Int J Cancer 128, 1327-1334.
54. Bueno MJ, Perez de Castro I, Gomez de Cedron M, Santos J, Calin GA, Cigudosa JC, Croce CM, Fernandez-Piqueras J, &, Malumbres M, (2008) Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression. Cancer Cell 13, 496-506. (Pubitemid 351763902)
55. Brueckner B, Stresemann C, Kuner R, Mund C, Musch T, Meister M, Sultmann H, &, Lyko F, (2007) The human let-7a-3 locus contains an epigenetically regulated microRNA gene with oncogenic function. Cancer Res 67, 1419-1423. (Pubitemid 46383365)
56. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M, et al. (2004) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 101, 2999-3004. (Pubitemid 38327724)
57. Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H, Harano T, Yatabe Y, Nagino M, Nimura Y, et al. (2004) Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 64, 3753-3756. (Pubitemid 38697282)
58. Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A, Labourier E, Reinert KL, Brown D, &, Slack FJ, (2005) RAS is regulated by the let-7 microRNA family. Cell 120, 635-647. (Pubitemid 40343076)
59. Wilkinson LS, Davies W, &, Isles AR, (2007) Genomic imprinting effects on brain development and function. Nat Rev Neurosci 8, 832-843. (Pubitemid 350006217)
60. Steenman MJ, Rainier S, Dobry CJ, Grundy P, Horon IL, &, Feinberg AP, (1994) Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumour. Nat Genet 7, 433-439. (Pubitemid 24204423)
61. Peters J, &, Robson JE, (2008) Imprinted noncoding RNAs. Mamm Genome 19, 493-502.
62. Simon JA, &, Kingston RE, (2009) Mechanisms of polycomb gene silencing: knowns and unknowns. Nat Rev Mol Cell Biol 10, 697-708.
63. Simon JA, &, Lange CA, (2008) Roles of the EZH2 histone methyltransferase in cancer epigenetics. Mutat Res 647, 21-29.
64. Sander S, Bullinger L, Klapproth K, Fiedler K, Kestler HA, Barth TF, Moller P, Stilgenbauer S, Pollack JR, &, Wirth T, (2008) MYC stimulates EZH2 expression by repression of its negative regulator miR-26a. Blood 112, 4202-4212.
65. Varambally S, Cao Q, Mani RS, Shankar S, Wang X, Ateeq B, Laxman B, Cao X, Jing X, Ramnarayanan K, et al. (2008) Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. Science 322, 1695-1699.
66. Friedman JM, Liang G, Liu CC, Wolff EM, Tsai YC, Ye W, Zhou X, &, Jones PA, (2009) The putative tumor suppressor microRNA-101 modulates the cancer epigenome by repressing the polycomb group protein EZH2. Cancer Res 69, 2623-2629.
67. Gandellini P, Folini M, Longoni N, Pennati M, Binda M, Colecchia M, Salvioni R, Supino R, Moretti R, Limonta P, et al. (2009) miR-205 Exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon. Cancer Res 69, 2287-2295.
68. Juan AH, Kumar RM, Marx JG, Young RA, &, Sartorelli V, (2009) Mir-214-dependent regulation of the polycomb protein Ezh2 in skeletal muscle and embryonic stem cells. Mol Cell 36, 61-74.
69. Lee CJ, Dosch J, &, Simeone DM, (2008) Pancreatic cancer stem cells. J Clin Oncol 26, 2806-2812.
70. Liu S, Dontu G, Mantle ID, Patel S, Ahn NS, Jackson KW, Suri P, &, Wicha MS, (2006) Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res 66, 6063-6071.
71. Godlewski J, Nowicki MO, Bronisz A, Williams S, Otsuki A, Nuovo G, Raychaudhury A, Newton HB, Chiocca EA, &, Lawler S, (2008) Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. Cancer Res 68, 9125-9130.
72. Lessard J, &, Sauvageau G, (2003) Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 423, 255-260. (Pubitemid 40852690)
73. Wang H, Garzon R, Sun H, Ladner KJ, Singh R, Dahlman J, Cheng A, Hall BM, Qualman SJ, Chandler DS, et al. (2008) NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma. Cancer Cell 14, 369-381.
74. van der Vlag J, &, Otte AP, (1999) Transcriptional repression mediated by the human polycomb-group protein EED involves histone deacetylation. Nat Genet 23, 474-478.
75. Witt O, Deubzer HE, Milde T, &, Oehme I, (2009) HDAC family: what are the cancer relevant targets? Cancer Lett 277, 8-21.
76. Vire E, Brenner C, Deplus R, Blanchon L, Fraga M, Didelot C, Morey L, Van Eynde A, Bernard D, Vanderwinden JM, et al. (2006) The Polycomb group protein EZH2 directly controls DNA methylation. Nature 439, 871-874. (Pubitemid 43255707)
77. Lehnertz B, Ueda Y, Derijck AA, Braunschweig U, Perez-Burgos L, Kubicek S, Chen T, Li E, Jenuwein T, &, Peters AH, (2003) Suv39h-mediated histone H3 lysine 9 methylation directs DNA methylation to major satellite repeats at pericentric heterochromatin. Curr Biol 13, 1192-1200. (Pubitemid 36872941)
78. Rajewsky N, (2006) microRNA target predictions in animals. Nat Genet 38 (Suppl), S8-S13.
79. Fabbri M, Garzon R, Cimmino A, Liu Z, Zanesi N, Callegari E, Liu S, Alder H, Costinean S, Fernandez-Cymering C, et al. (2007) MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci USA 104, 15805-15810. (Pubitemid 350035380)
80. Garzon R, Liu S, Fabbri M, Liu Z, Heaphy CE, Callegari E, Schwind S, Pang J, Yu J, Muthusamy N, et al. (2009) MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. Blood 113, 6411-6418.
81. Duursma AM, Kedde M, Schrier M, le Sage C, &, Agami R, (2008) miR-148 targets human DNMT3b protein coding region. RNA 14, 872-877. (Pubitemid 351574909)
82. Fujita PA, Rhead B, Zweig AS, Hinrichs AS, Karolchik D, Cline MS, Goldman M, Barber GP, Clawson H, Coelho A, et al. (2010) The UCSC genome browser database: update 2011. Nucleic Acids Res 39, D876-D882.
83. Lu L, Katsaros D, de la Longrais IA, Sochirca O, &, Yu H, (2007) Hypermethylation of let-7a-3 in epithelial ovarian cancer is associated with low insulin-like growth factor-II expression and favorable prognosis. Cancer Res 67, 10117-10122. (Pubitemid 350070782)
84. Datta J, Kutay H, Nasser MW, Nuovo GJ, Wang B, Majumder S, Liu CG, Volinia S, Croce CM, Schmittgen TD, et al. (2008) Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis. Cancer Res 68, 5049-5058.
85. Han L, Witmer PD, Casey E, Valle D, &, Sukumar S, (2007) DNA methylation regulates MicroRNA expression. Cancer Biol Ther 6, 1284-1288. (Pubitemid 351590384)
86. Lee KH, Lotterman C, Karikari C, Omura N, Feldmann G, Habbe N, Goggins MG, Mendell JT, &, Maitra A, (2009) Epigenetic silencing of MicroRNA miR-107 regulates cyclin-dependent kinase 6 expression in pancreatic cancer. Pancreatology 9, 293-301.
87. Saito Y, Friedman JM, Chihara Y, Egger G, Chuang JC, &, Liang G, (2009) Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells. Biochem Biophys Res Commun 379, 726-731.
88. Pallasch CP, Patz M, Park YJ, Hagist S, Eggle D, Claus R, Debey-Pascher S, Schulz A, Frenzel LP, Claasen J, et al. (2009) miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia. Blood 114, 3255-3264.
89. Hoffman AE, Zheng T, Yi C, Leaderer D, Weidhaas J, Slack F, Zhang Y, Paranjape T, &, Zhu Y, (2009) microRNA miR-196a-2 and breast cancer: a genetic and epigenetic association study and functional analysis. Cancer Res 69, 5970-5977.
90. Kim S, Lee UJ, Kim MN, Lee EJ, Kim JY, Lee MY, Choung S, Kim YJ, &, Choi YC, (2008) MicroRNA miR-199a* regulates the MET proto-oncogene and the downstream extracellular signal-regulated kinase 2 (ERK2). J Biol Chem 283, 18158-18166.
91. Grady WM, Parkin RK, Mitchell PS, Lee JH, Kim YH, Tsuchiya KD, Washington MK, Paraskeva C, Willson JK, Kaz AM, et al. (2008) Epigenetic silencing of the intronic microRNA hsa-miR-342 and its host gene EVL in colorectal cancer. Oncogene 27, 3880-3888. (Pubitemid 351862055)
92. Meng F, Wehbe-Janek H, Henson R, Smith H, &, Patel T, (2008) Epigenetic regulation of microRNA-370 by interleukin-6 in malignant human cholangiocytes. Oncogene 27, 378-386.
93. Saito Y, Suzuki H, Tsugawa H, Nakagawa I, Matsuzaki J, Kanai Y, &, Hibi T, (2009) Chromatin remodeling at Alu repeats by epigenetic treatment activates silenced microRNA-512-5p with downregulation of Mcl-1 in human gastric cancer cells. Oncogene 28, 2738-2744.
94. Noonan EJ, Place RF, Pookot D, Basak S, Whitson JM, Hirata H, Giardina C, &, Dahiya R, (2009) miR-449a targets HDAC-1 and induces growth arrest in prostate cancer. Oncogene 28, 1714-1724.
95. Chen JF, Mandel EM, Thomson JM, Wu Q, Callis TE, Hammond SM, Conlon FL, &, Wang DZ, (2006) The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 38, 228-233. (Pubitemid 43177239)
96. Mann J, Chu DC, Maxwell A, Oakley F, Zhu NL, Tsukamoto H, &, Mann DA, (2010) MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis. Gastroenterology 138, 705-714.